Patients with gastric gastrinomas had older age, higher levels of gastrin, seemingly smaller tumor size (p = 0.024, 0.030, and 0.065, respectively), and usually lower grade in differentiation (p = 0.035). The gene discussed is GAST; the disease is gastric gastrin-producing neuroendocrine tumor.